Connect with us

Cannabis News

Digipath’s GroSciences’ TERPO+ Broadspectrum Tests Advance For Its Plant-Derived Pesticide




Independent testing laboratory and formulation firm Digipath, Inc. has announced that its GroSciences division has completed preliminary validation testing on its natural plant-derived pesticide TERPO+ Broadspectrum that awaits patenting.

This product has the potential to serve a massive market and protect marijuana plants from microorganisms.

Testing has proven that TERPO+ Broadspectrum serves as a treatment for eliminating microbial bioburden on hemp and cannabis plants. Microbial bioburden and microorganism are the biggest contributors in cannabis plant loss.

Recent experiments on cannabis flower have shown that GroSciences’ TERPO+ Broadspectrum is effective in decontaminating cannabis and hemp plants, and ensures that cannabis samples are within most states’ testing limits.

Test results show that TERPO+ Broadspectrum reduced CFU/g with up to 91% compared to untreated samples.

According to the Chief Science Officer of Digipath Inc. Dr. Cindy Orser, the preliminary validation test successfully treated a sample that had failed a state microbial test previously.

After treatment with TERPO+ Broadspectrum, the sample passed the test.

Denkin said that a product like TERPO+ Broadspectrum could treat plants material effectively and help make it a sellable product with huge potential. He added that they would continue moving forward with product development and testing so that they can introduce it to the market soonest possible.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.